Related Experiment Video
Updated: Mar 28, 2026

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019
Cord Blood Cells for Developmental Toxicology and Environmental Health
Dora Il'yasova1, Noreen Kloc1, Alexander Kinev2
1Division of Epidemiology and Biostatistics, School of Public Health, Georgia State University , Atlanta, GA , USA.
Abstract:
The Tox21 program initiated a shift in toxicology toward in vitro testing with a focus on the biological mechanisms responsible for toxicological response. We discuss the applications of these initiatives to developmental toxicology. Specifically, we briefly review current approaches that are widely used in developmental toxicology to demonstrate the gap in relevance to human populations. An important aspect of human relevance is the wide variability of cellular responses to toxicants. We discuss how this gap can be addressed by using cells isolated from umbilical cord blood, an entirely non-invasive source of fetal/newborn cells. Extension of toxicological testing to collections of human fetal/newborn cells would be useful for better understanding the effect of toxicants on fetal development in human populations. By presenting this perspective, we aim to initiate a discussion about the use of cord blood donor-specific cells to capture the variability of cellular toxicological responses during this vulnerable stage of human development.
Insights
The Tox21 program advances in vitro toxicology. Using cord blood cells can improve understanding of toxicant effects on fetal development by capturing cellular response variability.
Area of Science:
- Toxicology
- Developmental Biology
- Cellular Biology
Background:
- The Tox21 program promotes in vitro testing focusing on toxicological mechanisms.
- Current developmental toxicology methods have limitations in human population relevance.
- Variability in cellular responses to toxicants is crucial for human relevance.
Purpose of the Study:
- To explore the application of in vitro toxicology initiatives in developmental toxicology.
- To address the gap in human relevance by utilizing cord blood cells.
- To propose using donor-specific cord blood cells for developmental toxicology testing.
Main Methods:
- Review of current developmental toxicology approaches.
- Discussion of using umbilical cord blood cells as a non-invasive source.
- Proposal for extending toxicological testing to human fetal/newborn cell collections.
Main Results:
- Identified a gap in the human relevance of current developmental toxicology methods.
- Highlighted umbilical cord blood as a valuable, non-invasive source of fetal/newborn cells.
- Proposed a novel approach to capture cellular response variability in toxicological testing.
Conclusions:
- Umbilical cord blood cells offer a promising avenue for improving developmental toxicology.
- Testing with donor-specific cells can better reflect human variability in toxicological responses.
- This approach can enhance understanding of toxicant effects during vulnerable developmental stages.
Related Concept Videos
Toxicity Testing in Animals
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Regulation of Hematopoietic Stem Cells

